13 results were returned
The worldwide COVID-19 pandemic has led to a scramble for pharmaceutical and medical devices which can prevent or treat COVID-19 infections. Currently there is no vaccine or treatment for COVID-19 ...
On 14 March 2020, the Spanish Government formally declared the "state of alarm", which implies amongst other measures the limitation of citizens' circulation rights and general closure of retail commerce.
The European Commission just published guidelines on the restrictions of the free movement principles in the context of the current COVID-19 crisis. Based on overriding public security and public health grounds, many ...
A new Infectious Diseases Act (the "Act") came into force on 1 March 2017 in Finland. As a new obligation, Section 48 of the Act stipulates that specific employees and interns in the health care sector must have ...
International law firm Bird & Bird has advised Chiesi Farmaceutici S.p.A. ("Chiesi") on the in-licence of Raxone® -- an orphan drug used in the treatment of Leber's hereditary optic neuropathy ("LHON")
International law firm Bird & Bird advises Mitsubishi Chemical Advanced Materials (MCAM), a leading global manufacturer of high-performance materials and a business division of Mitsubishi Chemical Corporation, Japan, on ...
We have advised Aphria Deutschland GmbH on its tender for the cultivation, processing and delivery of cannabis for medical purposes.
Bird & Bird are pleased to announce the promotion of three partners, as well as eight Senior Counsel/Counsel/Legal Directors from across our global offices.
In response to the COVID-19 outbreak, the Chinese government has issued a number of guidelines on the epidemic control and prevention to employers and the general public. What one can observe from the development of ...
In September 2018, employers and EU citizens welcomed the final report from the Migration Advisory Committee (MAC), which sketched the outline of a future migration landscape for EU workers.